<DOC>
	<DOCNO>NCT01586481</DOCNO>
	<brief_summary>It 's pilot prospective open multicentric randomise study . We measure efficiency safety new concept off-loading shoe ( SANIDIAB ) compare old one ( BAROUK ) treat chronic diabetic foot ulcer involve high risk amputation 64 diabetic patient plantar neuropathic ulcer fore foot without infection , osteomyelitis angiopathy , include . 32 patient treat SANIDIAB shoe 32 BAROUK shoe</brief_summary>
	<brief_title>Off- Loading Shoe Improve Healing Prevention Recurrence Neuropathic Diabetic Plantar Foot Ulcers</brief_title>
	<detailed_description>Name study : SANIBA Objective : The gold standard heal diabetic foot ulcer complete off-loading . To wear continuously load shoe difficult The bad compliance patient lead infection ulcer amputation foot . The purpose study compare efficacy new concept off-loading shoe ( pair SANIDIAB shoe ) single BAROUK shoe treat chronic plantar diabetic foot ulcer fore foot . The hypothesis new concept efficient good off-loading associate best compliance wear new concept shoe . The study last 18 month duration study 6 month per patient It 's pilot prospective multicenter randomise study 64 diabetic patient plantar neuropathic ulcer fore foot , treat randomisation load shoe BAROUK pair load shoe SANIDIAB . Patients follow diabetic foot department every 14 day heal heal 6 month inclusion study . The main outcome measure heal duration diabetic foot ulcer group treatment . The secondary outcome measure rate reulceration healing , rate amputation compliance patient 64 patient include 2 group : 32 wear SANIDIAB shoe 32 BAROUK shoe .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Inclusion criterion : More 18 year old man woman Type 1 2 Diabetes mellitus A new plantar ulcer fore foot toe GRADE 1A 2 A University Texas Classification Neuropathy assess absence sensation 10g monofilament test Exclusion criterion Severe angiopathy ( Grade 3 PEDIS classification ) Osteomyelitis cellulitis foot Transmetatarsal amputation Other study course Immunosuppressive drug , antibiotic therapy , Hepatic insufficiency No possibility follow patient every 14 day No state health insurance Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Diabetic foot ulcer</keyword>
	<keyword>Off load</keyword>
	<keyword>Compliance</keyword>
	<keyword>Healing duration</keyword>
	<keyword>Amputation rate</keyword>
</DOC>